Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
New TECFIDERA® (dimethyl fumarate) data show sustained efficacy and long-term safety in a broad range of multiple sclerosis patients
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.
Autoantibodies and pain.
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Recent insights into the mechanism of action of glatiramer acetate.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Multiple sclerosis prevalence in the United States commercially insured population.

Pages